Infectious Diseases Specialists to FDA: Don’t Cut Corners in COVID-19 Vaccine Approval

The Infectious Diseases Society of America and its HIV Medicine Association are urging the Food and Drug Administration to ensure rigorous safety and efficacy data support the approval of a COVID-19 vaccine before its widespread use by the public.  

IDSA/HIVMA Statement on Changes to CDC Guidance

IDSA and HIVMA call for the immediate reversal of the abrupt revision of the CDC COVID-19 testing guidelines which diminish the importance of testing asymptomatic individuals who were exposed to COVID-19. The revision is concerning, particularly as the United States continues to lead the world in confirmed cases and deaths, with more than 5.8 million cases and nearly 180,000 lives lost to the virus.

Three Decades of the Ryan White HIV/AIDS Program Have Set an Example, and a Path Forward

Today we mark the 30th anniversary of the Ryan White HIV/AIDS Program, a lifesaving program passed as the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act by Congress in 1990 with overwhelming bipartisan support, in response to a deadly virus made all the more destructive by stigma and misinformation.

As COVID-19 Cases Approach 5 Million in U.S., Infectious Diseases Leaders Call on White House for Unified Action on Masks

In a letter sent to Vice President Mike Pence today, leaders of the Infectious Diseases Society of America and its HIV Medicine Association are urging the White House to issue a strong federal directive calling for mask requirements in all states to curtail the spread of COVID-19 across this country, protect the economy and safely reopen schools.

IDSA, HIVMA Urge Inclusion of People Living with HIV in COVID-19 Clinical Trials

In a letter sent Wednesday to officials heading federal efforts to develop a vaccine against COVID-19, leaders of the Infectious Diseases Society of America and its HIV Medicine Association have urged that participation in clinical trials of vaccine candidates be open to people living with HIV.

Senate Republican COVID-19 Relief Responses Represent Progress but Fall Short of Critical Needs

A series of proposed COVID-19 bills released by Senate Republicans Monday represent a step toward urgently needed relief and resources, but fall short of necessary responses.

HIVMA Chair on Rep. John Lewis’ Commitment to Health Equity & HIV

Congressman John Lewis was a hero and leader like no other. His unwavering fight for civil rights and health equity included a special commitment to conquering HIV

Organizations Call for Reversal of Administration Policy Bypassing CDC with COVID-19 Data

More than 100 public health, science, research and medical organizations are urging the White House  to reverse a new policy that would divert COVID-19 patient data collection from the U.S. Centers for Disease Control and Prevention.

House Appropriations Committee Fiscal Year 2021 Labor Health and Human Services Funding Bill Recognizes New and Ongoing Health Threats, With Some Gaps

The House Labor Health and Human Services funding bill for fiscal year 2021 passed in committee this week reflects recognition of the crisis presented by the COVID-19 pandemic, and of the importance of limiting its impacts.

Withdrawal from WHO Leaves U.S. More Vulnerable to COVID-19 and Future Pandemics

The administration’s decision to withdraw the United States from the World Health Organization comes at a juncture of the COVID-19 pandemic when more than 12.1 million people have been diagnosed with COVID-19 and more than 550,000 people have died worldwide.

HIVMA Stands with Science and Anthony Fauci, MD

We have been very fortunate to have Dr. Anthony Fauci at the helm directing infectious diseases research at NIH for so many years. His leadership and support of a rigorous scientific process has been critical to transforming HIV from a death sentence to a chronic condition​, saving millions of lives worldwide.

Response from IDSA President to New COVID-19 Data Reporting Protocol

Reports that the administration has established a procedure that would remove the Centers for Disease Control and Prevention as a recipient of data on patients hospitalized with COVID-19 are troubling and, if implemented, will undermine our nation’s public health experts.